Cargando…
Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
Neuroendocrine differentiation (NED) in prostate cancer is a well-recognized phenotypic change by which prostate cancer cells transdifferentiate into neuroendocrine-like (NE-like) cells. NE-like cells lack the expression of androgen receptor and prostate specific antigen, and are resistant to treatm...
Autores principales: | Hu, Chang-Deng, Choo, Richard, Huang, Jiaoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396194/ https://www.ncbi.nlm.nih.gov/pubmed/25927031 http://dx.doi.org/10.3389/fonc.2015.00090 |
Ejemplares similares
-
JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer
por: Pawar, Jogendra Singh, et al.
Publicado: (2023) -
Glycosylation Changes in Prostate Cancer Progression
por: Butler, William, et al.
Publicado: (2021) -
Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms
por: Butler, William, et al.
Publicado: (2021) -
The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014) -
Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
por: Grigore, Alexandru Dan, et al.
Publicado: (2015)